ArticleJournal of clinical medicine2025

Oral Semaglutide Therapy Reduces Cardiovascular Events in Patients with Type 2 Diabetes: Deciphering the Soul of the Study.

Ishwarlal Jialal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.